Over the past 12 months, $VTGN generated 92 mentions from 2 distinct FinTwit voices, with the first mention appearing on December 17, 2025. The dominant voice discussing VistaGen Therapeutics was @acinvestorblog (Antonio Costa), who accounted for 91 of these mentions, while @investmentguru_ contributed 1 mention. The discussion category centered on long research analysis throughout this period.

Activity around $VTGN remained consistent through mid-2026, with @acinvestorblog posting updates through early July. Recent posts noted technical movements in the stock, including comments on daily highs and volume patterns. The most recent mention occurred on July 2, 2026, when @acinvestorblog posted that "$VTGN back up," following earlier observations about the stock continuing to make higher-of-day levels on volume and moving into a price gap.